Jennifer Chien
Corporate Officer/Principal at RHYTHM PHARMACEUTICALS, INC.
Net worth: 261 404 $ as of 2024-04-29
Jennifer Chien active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-11-08 | - |
Career history of Jennifer Chien
Former positions of Jennifer Chien
| Companies | Position | Start | End |
|---|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 2020-01-19 | 2020-10-15 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 2014-10-31 | 2019-12-31 |
Training of Jennifer Chien
| Massachusetts Institute of Technology | Undergraduate Degree |
| Harvard University | Graduate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jennifer Chien
- Experience
